COSCIENS Biopharma Inc
CSCI3.965USD
+0.145+3.81%
交易中 （美東）報價延遲15分鐘
12.48M總市值
虧損本益比TTM
關於 COSCIENS Biopharma Inc 公司
COSCIENS Biopharma Inc.（前身爲 Aeterna Zentaris Inc.）是一家專業生物製藥公司，致力於開發和商業化各種藥品和診斷產品組合，包括專注於未滿足醫療需求領域的產品。其主要產品 macimorelin（Macrilen；Ghryvelin）是一種口服測試，用於診斷成人生長激素缺乏症 (AGHD)。該公司還致力於開發治療資產和專有提取技術，該技術用於生產可再生植物資源中的活性成分，用於藥妝產品（即燕麥β-葡聚糖和燕麥生物鹼，它們存在於 Aveeno 和 Burt's Bees 等護膚品品牌配方中），並正在開發爲潛在的營養保健品和/或藥品。
公司簡介
公司代碼CSCI
公司名稱COSCIENS Biopharma Inc
上市日期Dec 19, 1995
CEOMs. Anna Biehn
員工數量- -
證券類型Ordinary Share
年結日Dec 19
公司地址C/O Norton Rose Fulbright Canada Llp
城市TORONTO
上市交易所The Toronto Stock Exchange
國家Canada
郵編M5K 1E7
電話18439003201
網址https://www.cosciensbio.com/
公司代碼CSCI
上市日期Dec 19, 1995
CEOMs. Anna Biehn
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Mr. Gilles R. Gagnon
Mr. Gilles R. Gagnon
Director
Director
41.96K
--
Dr. Ulrich Kosciessa
Dr. Ulrich Kosciessa
Director
Director
1.85K
--
Ms. Nicola Ammer
Ms. Nicola Ammer
Senior Vice President - Clinical Development, Chief Medical Officer
Senior Vice President - Clinical Development, Chief Medical Officer
--
--
Mr. Pierre Labbe, CPA
Mr. Pierre Labbe, CPA
Director
Director
--
--
Dr. Matthias Gerlach
Dr. Matthias Gerlach
Senior Vice President - Manufacturing and Supply Chain, Managing Director - AEZS Germany
Senior Vice President - Manufacturing and Supply Chain, Managing Director - AEZS Germany
--
--
Mr. Giuliano La Fratta
Mr. Giuliano La Fratta
Chief Financial Officer, Senior Vice President, Director
Chief Financial Officer, Senior Vice President, Director
--
--
Ms. Genevieve Foster
Ms. Genevieve Foster
Director
Director
--
--
Dr. William W. Li, M.D.
Dr. William W. Li, M.D.
Director
Director
--
--
Mr. Michel Regnier
Mr. Michel Regnier
Senior Vice President, Chief Technology Officer
Senior Vice President, Chief Technology Officer
--
--
Mr. Ronald W. (Ronnie) Miller
Mr. Ronald W. (Ronnie) Miller
Chairman of the Board
Chairman of the Board
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Gilles R. Gagnon
Mr. Gilles R. Gagnon
Director
Director
41.96K
--
Dr. Ulrich Kosciessa
Dr. Ulrich Kosciessa
Director
Director
1.85K
--
Ms. Nicola Ammer
Ms. Nicola Ammer
Senior Vice President - Clinical Development, Chief Medical Officer
Senior Vice President - Clinical Development, Chief Medical Officer
--
--
Mr. Pierre Labbe, CPA
Mr. Pierre Labbe, CPA
Director
Director
--
--
Dr. Matthias Gerlach
Dr. Matthias Gerlach
Senior Vice President - Manufacturing and Supply Chain, Managing Director - AEZS Germany
Senior Vice President - Manufacturing and Supply Chain, Managing Director - AEZS Germany
--
--
Mr. Giuliano La Fratta
Mr. Giuliano La Fratta
Chief Financial Officer, Senior Vice President, Director
Chief Financial Officer, Senior Vice President, Director
--
--
收入明細
單位: USD更新時間: 4月6日 週日
單位: USD更新時間: 4月6日 週日
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
暫無數據
地區USD
名稱
營收
佔比
Switzerland
4.32M
95.98%
Ireland
122.00K
2.71%
Other
48.00K
1.07%
Denmark
11.00K
0.24%
業務
地區
暫無數據
股東統計
更新時間: 8月1日 週五
更新時間: 8月1日 週五
持股股東
股東類型
持股股東
持股股東
佔比
Goodwood Inc.
8.18%
Gagnon (Gilles R)
1.33%
Susquehanna International Group, LLP
0.38%
RBC Dominion Securities, Inc.
0.12%
TD Waterhouse Canada, Inc.
0.12%
Other
89.87%
持股股東
持股股東
佔比
Goodwood Inc.
8.18%
Gagnon (Gilles R)
1.33%
Susquehanna International Group, LLP
0.38%
RBC Dominion Securities, Inc.
0.12%
TD Waterhouse Canada, Inc.
0.12%
Other
89.87%
股東類型
持股股東
佔比
Investment Advisor/Hedge Fund
8.19%
Individual Investor
1.49%
Investment Advisor
0.70%
Research Firm
0.11%
Bank and Trust
0.04%
Other
89.47%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
37
331.27K
10.53%
-6.89K
2025Q1
40
333.44K
10.61%
+29.17K
2024Q4
39
327.35K
8.67%
+13.77K
2024Q3
37
287.99K
7.73%
+16.16K
2024Q2
43
256.95K
8.09%
+189.65K
2024Q1
39
61.15K
4.98%
+40.02K
2023Q4
42
13.03K
1.07%
-9.47K
2023Q3
49
18.14K
1.49%
-6.74K
2023Q2
52
14.44K
1.19%
-13.85K
2023Q1
54
14.56K
1.20%
-15.46K
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Goodwood Inc.
257.26K
8.18%
--
--
Jun 03, 2025
Gagnon (Gilles R)
41.96K
1.33%
--
--
Mar 26, 2025
Susquehanna International Group, LLP
11.91K
0.38%
+11.91K
--
Mar 31, 2025
RBC Dominion Securities, Inc.
3.87K
0.12%
-69.00
-1.75%
Mar 31, 2025
TD Waterhouse Canada, Inc.
3.72K
0.12%
--
--
Mar 31, 2025
Desjardins Securities Inc.
2.81K
0.09%
-1.06K
-27.39%
Mar 31, 2025
Li (William W. M.D.)
2.40K
0.08%
--
--
Mar 26, 2025
UBS Financial Services, Inc.
2.34K
0.07%
+1.65K
+240.67%
Mar 31, 2025
Kosciessa (Ulrich)
1.85K
0.06%
--
--
Jun 03, 2025
National Bank of Canada
1.12K
0.04%
-4.80K
-81.05%
Mar 31, 2025
查看更多
持股ETF
機構名稱
佔比
暫無數據
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
May 01, 2024
Merger
4<1
May 01, 2024
Merger
4<1
May 01, 2024
Merger
4<1
May 01, 2024
Merger
4<1
Jul 19, 2022
Merger
25<1
Jul 19, 2022
Merger
25<1
公告日期
類型
比率
May 01, 2024
Merger
4<1
May 01, 2024
Merger
4<1
May 01, 2024
Merger
4<1
May 01, 2024
Merger
4<1
Jul 19, 2022
Merger
25<1
Jul 19, 2022
Merger
25<1
Jul 19, 2022
Merger
25<1
Jul 19, 2022
Merger
25<1
